Alnylam Pharma Stock Price (NASDAQ:ALNY)

Add to My Stocks
$104.62 $1.61 (1.52%) ALNY stock closing price Jun 19, 2018 (Closing)
Prev Close* : $106.23
Market Cap:
$10.68B
Day Low: $103.75
52 Week Low: $70.76
Open: $104.64
Volume: -
Day High: $105.78
52 Week High: $153.99
Dividend:
0.00

Latest Stock Market News

Latest Articles

Alnylam Pharma News - From Partners

ALNY Stockcharts

View ALNY PE ratio, PS ratio stocks charts and compare with peers.
ALNY Chart
Note: Compare Alnylam Pharma stock price history with the index and industry peers.

Alnylam Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
112.65
PB ratio (
price to book ratio
)
8

Alnylam Pharma Returns

ROE
(return on equity)
-40%

Alnylam Pharma Financial Ratios

Asset Turnover
0.05
Receivables Turnover
3.46
Debt to Equity
0.02
Dividend Yield
0%

ALNY Industry Peers

Company Price Change (%)
Bioverativ Inc (BIVV)104.980.33 (0.32%)
Seattle Genetics (SGEN)65.780.03 (0.05%)
Sanofi (SNY)39.150.44 (1.11%)
Takeda Pharma (TKPYY)18.980.35 (1.81%)
Merck (MRK)61.030.04 (0.07%)
Arbutus Biopharma (ABUS)6.830.08 (1.19%)
Takeda Pharma (TKPYY)18.980.35 (1.81%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)143.9338.69 (36.76%)
Catalyst Biosciences (CBIO)10.461.35 (14.82%)
Array BioPharma (ARRY)191.5 (8.57%)
Fate Therapeutics (FATE)12.310.88 (7.7%)
Fortress Biotech (FBIO)3.080.16 (5.48%)
Regeneron Pharma (REGN)327.0711.46 (3.63%)
Alder BioPharma (ALDR)17.80.55 (3.19%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 20, 2018
CompanyPriceChange (%)
Athersys (ATHX)2.060.25 (10.82%)
ELOXX PHARMACT (ELOX)19.21.65 (7.91%)
Agenus (AGEN)2.530.17 (6.3%)
SESEN BIO INC (SESN)2.10.11 (4.98%)
Kindred Biosciences (KIN)100.5 (4.76%)
Idera Pharma (IDRA)1.490.07 (4.49%)
Sorrento Therapeutics (SRNE)70.3 (4.11%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 20, 2018

Alnylam Pharmaceuticals, Inc. Stock News - Partner Headlines

Alnylam Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues89.91M47.15M41.09M50.56M47.16M
Net Income-490.87M-410.1M-290.07M-360.39M-89.22M
Total Operating Expense589.99M471.74M337.1M455.53M140.1M
View Alnylam Pharma income statement
balance sheet20172016201520142013
Total Assets1.99B1.26B1.39B1.08B420.53M
Total Liabilities228.29M342.58M121.79M143.32M150.18M
Shareholders Equity1.77B920.22M1.26B936.26M270.34M
View Alnylam Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.9M17.21M35.11M-29.4M-8.11M
Net Cash from (used by) Operating Activities-382.78M-307.7M-189.14M-165.64M-68.65M
Increase (Decrease) in Prop Plant And Equipment-104.2M-64.55M-12.95M-8.96M-4M
View Alnylam Pharma cash flow statement

Alnylam Pharma Stock Message Board

Alnylam Pharma stock price ended the last trading day at $104.62. The total market value as denoted by $10.68B for Alnylam Pharma, is the market value of the company's outstanding shares. Alnylam Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ALNY stock than sell it, then Alnylam Pharma stock price goes up. Conversely, if more investors wanted to sell ALNY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Alnylam Pharma stock quote data shows the number of shares traded. For Ex: 664,481 Alnylam Pharma shares were traded as of last trading day, as seen from Alnylam Pharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Alnylam Pharma dividend per share was 0.00 during the last quarter. Alnylam Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.